SCHEMBL23947718

SCHEMBL23947718

CCCc1nc(N2CCN(C(=O)CCl)CC2)c2c3c(sc2n1)CC(C)CC3

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.86
KMT2A Q03164 5/20 0.86
NPC1 O15118 1/20 0.73
POLB P06746 1/20 0.73
RAB9A P51151 1/20 0.73
ATM Q13315 1/20 0.73
CYP2C9 P11712 3/20 0.59
CYP2C19 P33261 3/20 0.59
CYP1A2 P05177 2/20 0.59
CNR1 P21554 5/20 0.57
GPR55 Q9Y2T6 4/20 0.57
CNR2 P34972 3/20 0.53
NPSR1 Q6W5P4 4/20 0.52
ALDH1A1 P00352 4/20 0.52
MAPT P10636 2/20 0.52
LMNA P02545 1/20 0.52
MAPK1 P28482 1/20 0.52
GUSB P08236 1/20 0.48
ADRB1 P08588 1/20 0.48
RECQL P46063 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29763649 1.00 MEN1 (0.86) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL23947742 0.95 MEN1 (0.83) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL29763686 0.95 MEN1 (0.83) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL29763659 0.81 MEN1 (0.62) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL23947717 0.81 MEN1 (0.62) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL23947764 0.80 MEN1 (0.56) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL29763666 0.79 MEN1 (0.75) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL23947763 0.79 MEN1 (0.75) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL23947737 0.74 ALDH1A1 (0.63) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL29763674 0.74 ALDH1A1 (0.63) MEN1KMT2ANPC1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047626-A1 SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS THE TRUSTEES OF INDIANA UNIVERSITY 2023-02-16 US disclosed
US-20220142973-A1 SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS THE TRUSTEES OF INDIANA UNIVERSITY 2022-05-12 US disclosed
WO-2021212010-A2 SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS THE TRUSTEES OF INDIANA UNIVERSITY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230047626-A1 SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS TP53, EIF2AK2, POLI MEN1 3618/4885KMT2A 3300/4885NPC1 4138/4885
US-20220142973-A1 SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS TP53, EIF2AK2, POLI MEN1 3618/4885KMT2A 3300/4885NPC1 4138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.